Clinical Trial Update: Safety and Efficacy of SPH3127 on Treating Mild-moderate Essential Hypertension Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update on SPH3127 for mild-to-moderate essential hypertension evaluating safety and efficacy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Essential Hypertension

Drugs mentioned

• SPH3127

Snippet

Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd | Conditions: Hypertension,Essential | Phase 2 | Status: COMPLETED